Dr. Gerald V. Naccarelli, MD

Dr. Naccarelli practices at Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State.

Dr. Naccarelli's NPI, 1730137407, was assigned on May 5, 2006. Dr. Naccarelli graduated from Pennsylvania State University College of Medicine in 1976. Dr. Naccarelli holds Pennsylvania license MD020752E.

Dr. Naccarelli's primary practice is Penn State Health Milton S. Hershey Medical Center, at 500 University Drive, Hershey, PA 17033 in Dauphin County. The practice phone is (717) 531-8521.

Dr. Naccarelli's primary practice is Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State. Dr. Naccarelli is also affiliated with Lancaster General Hospital. The medical group on file is Penn State Health Milton S. Hershey Medical Center. Dmand AI also links Dr. Naccarelli to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Naccarelli practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Naccarelli's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Naccarelli is licensed in Pennsylvania.

CMS data shows 5,543 Medicare services from Dr. Naccarelli across 22 procedure codes in 2024, for 3,075 Medicare patients. Medicare paid $74,032 for them.

CMS counts 3,075 Medicare patients who saw Dr. Naccarelli in 2024. The largest group is 65 to 74, with 1,260 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Naccarelli's median patient age at 73, with 43% women.

In 2024, Dr. Naccarelli wrote 398 Medicare Part D claims for 122 patients. 87% of them were for generic drugs. CMS names the drug for 253 of them, across 10 drugs with 11 or more claims each, at $67,763 in total drug cost. In 2023, CMS named 322 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Naccarelli for performance year 2024, reported as part of a group. Dr. Naccarelli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 120 papers to Dr. Naccarelli, published from 2010 to 2025. 2022 was the busiest year, with 12. The most frequent topics are Atrial Fibrillation, Anti-Arrhythmia Agents and Amiodarone. Dr. Naccarelli has published most often in Am J Med. Dr. Naccarelli's most frequent co-authors are Peter R. Kowey, MD, Mario Gonzalez and Bernard J. Gersh, MBCHB.

Dmand AI links Dr. Naccarelli to 2 clinical trials. Conditions studied include Atrial Flutter and Atrial Fibrillation. Sanofi sponsors the most, 2. Open Payments lists research payments to Dr. Naccarelli that name 2 trials.

CMS Open Payments shows 423 general payments to Dr. Naccarelli from 17 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. Janssen Pharmaceuticals, Inc paid the most, $324,720. It also lists 14 research payments totaling $8,789 from 2018 to 2023, naming 2 clinical trials.

Dr. Naccarelli graduated from Pennsylvania State University College of Medicine in 1976.